A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
ATF6 Inhibitors and Uses Thereof
Patent Title: ATF6 inhibitors and uses thereofPriority Filing Date: April 6, 2019Published As: US 10829485 B2 Assigned to: Later assigned to Altos Labs, Inc. (via assignment from Praxis Biotech LLC) What This Patent Covers This…
-
mRNA Delivery Platforms — Literature vs. Patents
1. Scientific Literature: Focus on Mechanisms & Innovation Lipid nanoparticles (LNPs) remain the dominant delivery mechanism in academic research because they protect fragile mRNA from degradation and enable cellular uptake. Researchers describe how particle composition,…
-
Antibody–Drug Conjugates
1. Component-level protection Most valuable claims start at the basics: Antibody sequences and formats (e.g., CDRs, variable regions, humanized/human frameworks) Linkers and linker chemistry Payloads (cytotoxins) and derivatives Specific combinations of antibody + linker +…
